Several options exist for women experiencing low sexual desire, ranging from FDA-approved medications to hormonal treatments and lifestyle changes. The right choice depends on what’s causing the problem: hormonal shifts, medication side effects, stress, or changes after menopause each point toward different solutions.
Understanding Why Desire Drops
Low sexual desire in women is formally recognized as a medical condition when four things are true: you were previously satisfied with your level of desire, that desire has noticeably decreased, the change bothers you, and you want it to improve. This distinction matters because desire naturally fluctuates throughout life, and a lower libido only becomes a problem worth treating when it causes personal distress.
Common causes include hormonal changes during perimenopause and menopause, side effects from antidepressants (particularly SSRIs, which affect sexual function in 30% to 50% of women taking them), relationship stress, fatigue, body image concerns, and chronic health conditions. Sometimes several of these overlap. Identifying the root cause helps determine which treatment is most likely to work.
FDA-Approved Medications for Low Desire
Two prescription medications are specifically approved for premenopausal women with persistently low sexual desire.
Flibanserin (Addyi)
Flibanserin is a daily pill taken at bedtime that works on brain chemistry related to desire. It’s not a quick fix. You take it every night, and it typically takes up to eight weeks to know whether it’s working. In clinical trials, 46% to 55% of premenopausal women on the drug reported meaningful improvement, compared to 34% to 44% on placebo. For postmenopausal women, the benefit was smaller but still measurable.
The most important safety concern involves alcohol. Taking flibanserin within two hours of drinking increases the risk of dangerously low blood pressure and fainting. Current FDA guidance says to wait at least two hours after one or two drinks before taking it at bedtime, and to skip the dose entirely if you’ve had three or more drinks that evening. It also interacts with certain other medications, so a prescriber needs your full medication list.
Bremelanotide (Vyleesi)
Bremelanotide takes a completely different approach. Instead of a daily pill, it’s a self-administered injection given at least 45 minutes before anticipated sexual activity. It activates receptors in the brain involved in arousal, though researchers still don’t fully understand the exact mechanism. The on-demand format appeals to some women who prefer not to take a daily medication. Nausea is the most commonly reported side effect, particularly with early doses.
Hormonal Options
Testosterone Therapy
Testosterone isn’t just a male hormone. Women produce it naturally, and levels decline with age. A global consensus statement from endocrinology societies supports testosterone therapy for women with low desire, but with important caveats. It’s prescribed off-label in most countries because no testosterone product is specifically approved for women. Doctors typically prescribe a male formulation at a much lower dose, aiming to keep blood levels within the normal premenopausal female range.
Before starting, your doctor should measure your baseline testosterone level, then recheck it three to six weeks into treatment. Monitoring continues every six months to watch for signs of excess, like acne or unwanted hair growth. If there’s no improvement after six months, guidelines recommend stopping. Pellet implants and injections are not recommended because they can push hormone levels too high. Compounded “bioidentical” testosterone preparations also lack sufficient safety and efficacy data, though they may be the only option in some regions.
Vaginal Hormonal Treatments
For women whose low desire stems from painful or uncomfortable sex after menopause, local treatments can make a significant difference. Vaginal dryness, thinning tissue, and pain during intercourse are extremely common after menopause, and they can suppress desire simply because sex has become unpleasant.
One option is a vaginal insert containing a synthetic form of DHEA, a compound the body naturally produces. Once applied, vaginal cells convert it into both estrogen and androgens locally, without meaningfully raising hormone levels throughout the body. In clinical trials, women using this treatment for 12 weeks saw meaningful improvements in dryness and pain during sex compared to placebo. Sexual function scores also improved across desire, arousal, lubrication, orgasm, and satisfaction. This option is particularly relevant for women who can’t use traditional estrogen therapy, such as breast cancer survivors or those with cardiovascular risk factors. Vaginal estrogen creams and rings work similarly for dryness and discomfort, though they don’t produce the local androgen component.
Switching or Adjusting Antidepressants
If an SSRI is suppressing your desire, one well-studied strategy is switching to or adding bupropion, an antidepressant that works through different brain pathways and tends to have fewer sexual side effects. A meta-analysis found bupropion was roughly three times more effective than placebo at improving sexual desire in women with SSRI-related problems. Interestingly, the analysis also found that a lower dose was more effective for desire than a higher one.
All four studies in the analysis showed significant improvement in sexual desire or interest among women with depression who had SSRI-induced sexual dysfunction. This doesn’t mean bupropion is right for everyone, since it treats depression differently than SSRIs and may not be appropriate for all conditions. But if sexual side effects from your current antidepressant are a major concern, it’s worth discussing with your prescriber.
Herbal Supplements
Ashwagandha and maca root are the two supplements most commonly marketed for female libido, but the evidence is mixed. A pilot study of 50 women taking 300 mg of ashwagandha root extract twice daily for eight weeks found significant improvements in arousal, lubrication, orgasm, and satisfaction compared to placebo. However, the desire domain specifically did not show a statistically significant improvement over placebo. The total number of sexual encounters also didn’t change. So while ashwagandha may improve the physical experience of sex, it doesn’t appear to directly increase wanting it.
Maca root has a handful of small studies suggesting modest benefits, but none are large or rigorous enough to draw firm conclusions. Supplements are not regulated the same way as medications, so quality and potency vary between brands. They’re generally considered safe for short-term use, but they shouldn’t be expected to produce the same results as prescription treatments.
What Realistic Improvement Looks Like
None of these treatments work like a light switch. Flibanserin requires eight weeks of nightly use before you can judge its effect. Testosterone therapy needs three to six months. Vaginal hormonal treatments show measurable results at 12 weeks. Even bremelanotide, the only on-demand option, works best after a few uses as your body adjusts to it.
The response rates in clinical trials are also worth understanding realistically. Roughly half of premenopausal women on flibanserin experience meaningful improvement, which means roughly half don’t. Testosterone helps many women, but guidelines are clear that it should be stopped at six months if there’s no benefit. The most effective approach often combines treatment with addressing underlying factors like stress, relationship dynamics, sleep quality, and overall health. Low desire is rarely caused by one thing alone, and the women who see the best outcomes typically address it from more than one angle.